Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bionano Genomics Inc (NQ: BNGO )

7.150 +0.250 (+3.62%)
Official Closing Price Updated: 5:27 PM EST, Mar 5, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Bionano Genomics Inc

< Previous 1 2 3 4 5 Next >
Bionano Customer Praxis Genomics Receives DEX Z-Codes from Palmetto for their Whole Genome Analysis LDT on Saphyr
From GlobeNewswire News Releases
Bionano Genomics to Present at the Cowen 41st Annual Health Care Conference
From GlobeNewswire News Releases
Bionano to be Featured at AGBT 2021 with Presentations of Scientific Discoveries made with Saphyr in Psychiatric Disorders and Cancer
From GlobeNewswire News Releases
Bionano’s Saphyr Data Prove Essential in Creating the Most Comprehensive, Ethnically Diverse Collection of Genome Variation Ever Completed
Article published in Science reveals that optical genome mapping uniquely makes thousands of large structural variant calls 
From GlobeNewswire News Releases
Thinking about buying stock in Nokia, BioNano Genomics, TJX Companies, Bank of America, or Advanced Micro Devices?
InvestorsObserver issues critical PriceWatch Alerts for NOK, BNGO, TJX, BAC, and AMD. 
From PR Newswire
Bionano Publishes Method for Identifying Genes Likely to Cause Neurological Diseases Based on a Model Developed by Lineagen to Improve Interpretation of Variants of Unknown Significance
Proprietary scoring algorithm may help identify novel genes for nervous system disorders; applications include patient testing and eventually discovery research with Saphyr 
From GlobeNewswire News Releases
Bionano Genomics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
From GlobeNewswire News Releases
Method for Solid Tumor Analysis with Saphyr Published by Penn State Institute for Personalized Medicine, Opening Largest Oncology Market to Optical Genome Mapping
Publication demonstrates that Saphyr can be powerful and easy to use for solid tumor analysis in cancer research and clinical testing 
From GlobeNewswire News Releases
Largest Hospital Diagnostic Lab in Canada Pilots Bionano’s Saphyr; Seeking to Convert 30-Year-Old Workflow Based on Multiple Technologies Into a Single, High-Resolution Assay to Transform Cancer Diagn
From GlobeNewswire News Releases
Presentation Recordings from Bionano’s Next-Generation Cytogenomics Symposium, its Most Attended Event to Date, Now Available Online
From GlobeNewswire News Releases
Thinking about buying stock in Durect Corp, T2 Biosystems, Gevo Inc, BioNano Genomics, or Advanced Micro Devices?
InvestorsObserver issues critical PriceWatch Alerts for DRRX, TTOO, GEVO, BNGO, and AMD. 
From PR Newswire
Saphyr Study Is First to Analyze Cancer Regulation at Level of Single DNA Molecules, Opens Promising New Avenue of Cancer Research
Publication on novel Saphyr based method to analyze DNA methylation in cancer genomes enables new field of cancer research and drug target discovery 
From GlobeNewswire News Releases
Dr. Gordana Raca from Children’s Hospital Los Angeles Presents Findings That Show Saphyr Detects Druggable Gene Fusions in Pediatric Acute Leukemias that NGS and Cytogenetics Missed
From GlobeNewswire News Releases
Bionano Chief Medical Officer Presents Vision for Optical Genome Mapping as a First Line Clinical Tool for Cancer and Genetic Disease Testing at Festival of Genomics & Biodata
From GlobeNewswire News Releases
Bionano Significantly Reduces Analysis Cost and Time to Actionable Results with Update to its Cloud Compute
Addition of Microsoft Azure as a High-Performance Computing provider reduces compute cost for genetic disease analysis by more than 50%, compute time by 30% 
From GlobeNewswire News Releases
Bionano Genomics Announces Closing of $230 Million Underwritten Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From GlobeNewswire News Releases
Bionano Genomics Announces Pricing of $200 Million Underwritten Public Offering of Common Stock
From GlobeNewswire News Releases
Bionano Genomics Announces Proposed Underwritten Public Offering of Common Stock
From GlobeNewswire News Releases
Thinking about buying stock in Gevo, Applied DNA Sciences, Surface Oncology, Aldeyra Therapeutics, or BioNano Genomics?
InvestorsObserver issues critical PriceWatch Alerts for GEVO, APDN, SURF, ALDX, and BNGO. 
From PR Newswire
MD Anderson Cancer Center Publication Shows How Bionano’s Saphyr System Can Significantly Reduce Time to Actionable Results for Myelodysplastic Syndrome Patients
From GlobeNewswire News Releases
Day Five of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Identifies Structural Variants that May Predispose to Severe COVID-19 Illness
From GlobeNewswire News Releases
Thinking about buying stock in Obseva SA, DBV Technologies, BlackBerry, Five Prime Therapeutics, or BioNano Genomics?
InvestorsObserver issues critical PriceWatch Alerts for OBSV, DBVT, BB, FPRX, and BNGO. 
From PR Newswire
Day Four of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Solves Genetic Mysteries, Enables Study of Complex Genetic Diseases, Simplifies Muscular Dystrophy Testing
From GlobeNewswire News Releases
Thinking about buying stock in Sundial Growers, FuelCell Energy, Nokia, BioNano Genomics, or Biolase?
InvestorsObserver issues critical PriceWatch Alerts for SNDL, FCEL, NOK, BNGO, and BIOL. 
From PR Newswire
Day Three of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Provides Complete Structural Variation Analysis in Solid Tumors, Enables Discovery of Novel Diagnostic Markers and Drug Targets
From GlobeNewswire News Releases
Bionano Genomics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement
From GlobeNewswire News Releases
Day Two of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Outperforms Standard Cytogenetics in Heme Malignancies, is Less Expensive, Provides Actionable Information Faster, in Single Assay
From GlobeNewswire News Releases
Bionano Genomics Announces Closing of $101.8 Million Underwritten Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
From GlobeNewswire News Releases
Thinking about buying stock in Biolase, Transocean, BP, AMC Entertainment, or BioNano Genomics?
InvestorsObserver issues critical PriceWatch Alerts for BIOL, RIG, BP, AMC, and BNGO. 
From PR Newswire
Day One of Bionano’s Next-Generation Cytogenomics Symposium: Customer Progress in Applications Development in Prenatal Testing, Validation Against Traditional Cytogenetics and Resolution for Undiagnos
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.